Don't wait until the end of the month for stories like these. Stay up-to-date with the latest in precision prevention news. Follow CancerIQ on social...
In a recent webinar hosted by the Association of Cancer Executives, CancerIQ’s Senior Vice President of Commercial Strategy, John Hansel, discussed...
Genomics has an established benefit in precision cancer care for patients and providers alike – but its positive financial impact on your health...
The CancerIQ product suite is an end-to-end solution, genetic history data gathering to supporting the management of high-risk care plans.
As the nation honors Black History Month and National Cancer Prevention Month, experts are calling attention to disparities in screening access and...
2021 prompted us to define the “new normal” in every facet of our lives, and cancer care was no exception.
President’s Cancer Panel: 5 takeaways on breast cancer screening, genetic testing access, and widening adoption of new technology.
Community centers lose revenue potential from patient leakage, up to $650,000, on average, per patient. But what if there were a way to plug those...
Fewer Americans have been getting cancer screenings since COVID-19 restrictions were put into place. To address concerns, Dr. Westgate and her team...
You need financial justification for your genetic services and cancer risk assessment. Learn why and how to calculate your ROI in the educational...